Position in MNOV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$271,128
+$10,965 QoQ
Shares Held
205,400
+8.2% QoQ
Ownership
0.417%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 29 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MNOV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. MNOV ranks #240 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in MNOV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $271,128 | 205,400 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $260,163 | 189,900 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $257,808 | 196,800 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $244,475 | 192,500 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $234,097 | 178,700 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $265,282 | 181,700 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $380,730 | 181,300 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $391,860 | 186,600 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $302,400 | 210,000 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $334,080 | 230,400 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $261,150 | 174,100 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $312,664 | 149,600 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $337,870 | 146,900 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $311,904 | 144,400 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $291,715 | 142,300 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $325,066 | 149,800 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $407,583 | 161,100 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $399,699 | 149,700 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $381,364 | 142,300 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $488,910 | 129,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $574,175 | 135,100 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $793,860 | 157,200 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,074,618 | 204,300 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,099,352 | 209,800 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,212,361 | 223,683 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $911,028 | 244,900 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||